Understanding immune cell trafficking patterns via in vivo bioluminescence imaging

Cell migration is a key aspect of the development of the immune system and mediating an immune response. There is extensive and continual redistribution of cells to different anatomic sites throughout the body. These trafficking patterns control immune function, tissue regeneration, and host responses to insult. The ability to monitor the fate and function of cells, therefore, is imperative to both understanding the role of specific cells in disease processes and to devising rational therapeutic strategies. Determining the fate of immune cells and understanding the functional changes associated with migration and proliferation require effective means of obtaining in vivo measurements in the context of intact organ systems. A variety of imaging methods are available to provide structural information, such as X‐ray CT and MRI, but only recently new tools have been developed that reveal cellular and molecular changes as they occur within living animals. We have pioneered one of these techniques that is based on the observations that light passes through mammalian tissues, and that luciferases can serve as internal biological sources of light in the living body. This method, called in vivo bioluminescence imaging, is a rapid and noninvasive functional imaging method that employs light‐emitting reporters and external photon detection to follow biological processes in living animals in real time. This imaging strategy enables the studies of trafficking patterns for a variety of cell types in live animal models of human biology and disease. Using this approach we have elucidated the spatiotemporal trafficking patterns of lymphocytes within the body. In models of autoimmune disease we have used the migration of “pathogenic” immune cells to diseased tissues as a means to locally deliver and express therapeutic proteins. Similarly, we have determined the tempo of NK‐T cell migration to neoplastic lesions and measured their life span in vivo. Using bioluminescence imaging individual groups of animals can be followed over time significantly reducing the number of animals per experiment, and improving the statistical significance of a study since changes in a given population can be studied over time. Such rapid assays that reveal cell fates in vivo will increase our basic understanding of the molecular signals that control these migratory pathways and will substantially speed up the development and evaluation of therapies. J. Cell. Biochem. Suppl. 39: 239–248, 2002. © 2002 Wiley‐Liss, Inc.

[1]  C. Contag,et al.  Visualizing the kinetics of tumor-cell clearance in living animals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  I. Tarner,et al.  The potential for gene therapy in the treatment of autoimmune disease. , 2002, Clinical immunology.

[3]  Michael Bachmann,et al.  Bioluminescent indicators for in vivo measurements of gene expression , 2002 .

[4]  R. Blasberg Imaging Gene Expression and Endogenous Molecular Processes: Molecular Imaging , 2002, Journal of Cerebral Blood Flow and Metabolism.

[5]  Daniel E. Hall,et al.  Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. , 2000, Neoplasia.

[6]  S. Gambhir,et al.  Optical imaging of Renilla luciferase reporter gene expression in living mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Contag,et al.  Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. , 2001, The Journal of clinical investigation.

[8]  U. V. Andrian T Cell Activation in Six Dimensions , 2002 .

[9]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[10]  J. Lieberman,et al.  A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Michael E. Phelps,et al.  Ex vivo cell labeling with 64Cu–pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S R Cherry,et al.  Detector development for microPET II: a 1 microl resolution PET scanner for small animal imaging. , 2001, Physics in medicine and biology.

[13]  C. Contag,et al.  In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  U. V. von Andrian,et al.  In situ analysis of lymphocyte migration to lymph nodes. , 1998, Cell adhesion and communication.

[15]  Christopher H Contag,et al.  Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3. , 2002, Cancer research.

[16]  C. Contag,et al.  It's not just about anatomy: In vivo bioluminescence imaging as an eyepiece into biology , 2002, Journal of magnetic resonance imaging : JMRI.

[17]  U. V. von Andrian Immunology. T cell activation in six dimensions. , 2002, Science.

[18]  S. Gambhir,et al.  Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging , 2002, Nature Medicine.

[19]  R. Day,et al.  Dual-function reporter protein for analysis of gene expression in living cells. , 1998, BioTechniques.

[20]  C. Contag,et al.  Adoptive Immunotherapy of Experimental Autoimmune Encephalomyelitis Via T Cell Delivery of the IL-12 p40 Subunit1 , 2001, The Journal of Immunology.

[21]  R. N. Goble,et al.  Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. , 2001, Physics in medicine and biology.

[22]  I. Weissman,et al.  Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. , 2002, Blood.

[23]  J. Nicolas Applications of low-light imaging to life sciences. , 1994, Journal of bioluminescence and chemiluminescence.

[24]  B. Rice,et al.  In vivo imaging of light-emitting probes. , 2001, Journal of biomedical optics.

[25]  F. Blankenberg,et al.  Nuclear medicine applications in molecular imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[26]  V. Cicinnati,et al.  Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope , 2000, Gene Therapy.

[27]  C. Contag,et al.  Revealing the spatiotemporal patterns of bacterial infectious diseases using bioluminescent pathogens and whole body imaging. , 2001, Contributions to microbiology.

[28]  Christopher H Contag,et al.  Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. , 2003, Blood.

[29]  Mark M. Davis,et al.  Dynamics of the immunological synapse: finding, establishing and solidifying a connection. , 2002, Current opinion in immunology.

[30]  D. Kohn,et al.  Immune response to green fluorescent protein: implications for gene therapy , 1999, Gene Therapy.

[31]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[32]  C. Contag,et al.  Noninvasive assessment of tumor cell proliferation in animal models. , 1999, Neoplasia.

[33]  R Weissleder,et al.  Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.

[34]  Ivo Que,et al.  Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. , 2002, The American journal of pathology.

[35]  C. Contag,et al.  Advances in in vivo bioluminescence imaging of gene expression. , 2002, Annual review of biomedical engineering.

[36]  W. Oyen,et al.  New concepts in infection/inflammation imaging. , 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[37]  W. Denk,et al.  Two-photon laser scanning fluorescence microscopy. , 1990, Science.

[38]  David K. Stevenson,et al.  Bioluminescent indicators in living mammals , 1998, Nature Medicine.

[39]  S S Gambhir,et al.  Noninvasive quantitative imaging of protein–protein interactions in living subjects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Larson,et al.  Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. , 2001, Neoplasia.